# China NMPA Drug Inspection - Yunnan Dongjun Pharmaceutical Group - mastic

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/yunnan-dongjun-pharmaceutical-group/0dd03416-fd9b-46d2-80a3-c0bb33cdc352/
Source feed: China

> China NMPA drug inspection for Yunnan Dongjun Pharmaceutical Group published January 12, 2017. Drug: mastic. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Announcement No. 5 of 2017 from the State Administration for Market Regulation on the Results of Special Sampling Inspections of Chinese Medicinal Herbs and Prepared Slices
- Company Name: Yunnan Dongjun Pharmaceutical Group
- Publication Date: 2017-01-12
- Drug Name: mastic
- Inspection Finding: Rosin acid was detected, indicating adulteration.
- Action Taken: We have taken timely and lawful measures to control the products, including sealing and seizing, suspending production and sales, and requiring companies to voluntarily recall their products. We have also filed cases against the relevant companies and units for investigation and punishment.

Company: https://www.globalkeysolutions.net/companies/yunnan-dongjun-pharmaceutical-group/62836393-451f-4c19-9c4e-c8362955342b/